Titan Biotech Limited at its AGM held on September 29, 2023 approved appointment of Shivom Singla and Udit Singla as Whole Time Directors and Dhairya Madan and Brijesh Kumar Singh as Independent Non-executive Directors. Mr. Dhairya Madan is an advocate with a keen business sense, advising & regularly representing individuals & corporations before the Hon'ble Supreme Court of India, the Hon'ble Delhi High Court and various Tribunals including the Hon'ble National Company Law Tribunal (NCLT), the Hon'ble National Company Law Appellate Tribunal (NCLAT), the Hon'ble National Green Tribunal (NGT) & the Hon'ble Income Tax Appellate Tribunal (ITAT), amongst others, in commercial disputes & policy matters. He advises clients in contract negotiations with multiple stakeholders including the Central & the State governments.

He undertakes Contract Management, while also handling all contentious & non-contentious litigation originating from ongoing contracts. He has a keen interest in Insolvency & Bankruptcy Law & Environmental Law, representing various corporations in prominent litigations affecting policy decisions. He is registered with the Bar Council of Delhi and is a member of the Delhi High Court Bar Association.

Mr. Brijesh Kumar Singh is a reputed advocate and Practicing law since 2007 in District Courts, High Court, Supreme Court of India & other Forums at Delhi mainly in the fields of Civil, Criminal, Rent & Matrimonial and also in Property, Company and Constitutional related matters. Currently, Mr. Shivom Singla is associated with Company as a Vice President-Bulk of the Company from 01/10/2019. He have an experience in Bulk section and other expertise over 11 years in Phoenix Bio Sciences Private Limited and over 3.5 years of experience in Titan Biotech Limited.

Currently, Mr. Udit Singla is associated with Company as a Vice President-Media of the Company from 01/10/2019. Experience in Culture Media Marketing for nearly 4 years. Date of Appointments & term of appointments: October 1, 2023 and Appointed in the category of Non-Executive Independent Director for a period of 5 (Five) years From October 1, 2023 up to September 30, 2028 (both days inclusive).